Quest Laboratories Ltd
NSE:QUESTLAB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Quest Laboratories Ltd
NSE:QUESTLAB
|
IN |
|
Gold Royalty Corp
F:6LS0
|
CA |
|
Alzchem Group AG
F:ACT0
|
DE |
Intrinsic Value
The intrinsic value of Quest Laboratories Ltd (QUESTLAB) under the Base Case is 74.68 INR per share.
Compared with the current market price of 94 INR, the stock appears
Overvalued by 21% .
The intrinsic value is calculated using the DCF method. The model assumes revenue grows about 22% in 2027, then slows: about 15% a year on average over the next five years, . Net margin ends at 13% by 2031, close to last year's 13%.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Quest Laboratories Does
Quest Laboratories Ltd. is engaged in the business of manufacturing pharmaceutical formulations. The company produces a variety of products, comprising ethical drugs, generic drugs, and over-the-counter drugs (OTC). These products are available in various forms, such as tablets, liquid orals, oral dry powders, oral powders (ORS), ointments, and external liquids. The tablets include Cetirizine Hydrochloride Tablet IP 10 mg, Zinc Sulphate Dispersible Tablet IP, Diclofenac Sodium Tablet BP, and others.
- Headquarters
- India IN
- Employees
- 50
- IPO date
- May 23, 2024
Earnings Waterfall
Quest Laboratories Ltd
The intrinsic value for Quest Laboratories Ltd (QUESTLAB) under the Base Case is 74.68 INR.
Compared with the current market price of 94 INR, the stock appears Overvalued by 21% .